Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Novartis

Novartis

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using Daylife platform, which helps you be more efficient and creative with content. It's designed for publishers, editors, and developers to build better content-based sites, services, and apps for clients and audiences. Learn More »

About Novartis

Wikipedia

Novartis International AG (NYSE: NVS) is a multinational pharmaceutical company based in Basel, Switzerland that manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate... Full Article

Related Photos

BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen as trade union members give information to employee on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net...
Pause Play 1/25
prev
  1. BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen as trade union members give information to employee on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net... Getty Images logo Getty Images 3 months ago

    BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen as trade union members give information to employee on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net...

    View Photo »
  2. BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD. Getty Images logo Getty Images 3 months ago

    BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD.

    View Photo »
  3. A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss... Reuters Pictures logo Reuters Pictures 3 months ago

    A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss...

    View Photo »
  4. The Novartis headquarters is seen in Basel in this September 1, 2011 file photo. A strong franc not withstanding, the Swiss pharmaceuticals industry is still stepping up investments in Basel. After 500 years, executives say it will take more than a currency crisis to move them on. To... Reuters Pictures logo Reuters Pictures 5 months ago

    The Novartis headquarters is seen in Basel in this September 1, 2011 file photo. A strong franc not withstanding, the Swiss pharmaceuticals industry is still stepping up investments in Basel. After 500 years, executives say it will take more than a currency crisis to move them on. To...

    View Photo »
  5. Novartis CEO Joe Jimenez is interviewed in Basel in this September 1, 2011 file photo. A strong franc not withstanding, the Swiss pharmaceuticals industry is still stepping up investments in Basel. After 500 years, executives say it will take more than a currency crisis to move them on. Reuters Pictures logo Reuters Pictures 5 months ago

    Novartis CEO Joe Jimenez is interviewed in Basel in this September 1, 2011 file photo. A strong franc not withstanding, the Swiss pharmaceuticals industry is still stepping up investments in Basel. After 500 years, executives say it will take more than a currency crisis to move them on.

    View Photo »
  6. This undated product photo provided by Novartis AG, shows the drug Reclast. Food and Drug Administration advisers voted Friday, Sept. 9, 2011 to require makers of widely used osteoporosis drugs to clarify how long patients should take them for the greatest benefit and least risk. AP Photo logo AP Photo 5 months ago

    This undated product photo provided by Novartis AG, shows the drug Reclast. Food and Drug Administration advisers voted Friday, Sept. 9, 2011 to require makers of widely used osteoporosis drugs to clarify how long patients should take them for the greatest benefit and least risk.

    View Photo »
  7. Novartis CEO Joe Jimenez attends an interview with Reuters at the company's headquarters in Basel September 1, 2011. Growth in emerging markets and trading the rich world up to more advanced implanted lenses are major untapped opportunities for Novartis's eyecare unit Alcon, the Swiss... Reuters Pictures logo Reuters Pictures 5 months ago

    Novartis CEO Joe Jimenez attends an interview with Reuters at the company's headquarters in Basel September 1, 2011. Growth in emerging markets and trading the rich world up to more advanced implanted lenses are major untapped opportunities for Novartis's eyecare unit Alcon, the Swiss...

    View Photo »
  8. Christoph Brutschin member of the government Canton Basel-Stadt speaks during a news conference in Bern January 17, 2012, on the preservation of the Novartis production site in Nyon/Prangins and the mitigation of the impact on proposed job cuts at the Novartis sites in Basel. Reuters Pictures logo Reuters Pictures 1 month ago

    Christoph Brutschin member of the government Canton Basel-Stadt speaks during a news conference in Bern January 17, 2012, on the preservation of the Novartis production site in Nyon/Prangins and the mitigation of the impact on proposed job cuts at the Novartis sites in Basel.

    View Photo »
  9. Pascal Brenneisen, Country President at Novartis Group Switzerland speaks during a news conference in Bern January 17, 2012, on the preservation of the Novartis production site in Nyon/Prangins and the mitigation of the impact on proposed job cuts at the Novartis sites in Basel. Reuters Pictures logo Reuters Pictures 1 month ago

    Pascal Brenneisen, Country President at Novartis Group Switzerland speaks during a news conference in Bern January 17, 2012, on the preservation of the Novartis production site in Nyon/Prangins and the mitigation of the impact on proposed job cuts at the Novartis sites in Basel.

    View Photo »
  10. Pascal Brenneisen (C) Country President at Novartis Group Switzerland speaks next to Philippe Leuba (L) member of the government Canton Vaud and Christoph Brutschin member of the government Canton Basel-Stadt during a news conference on the preservation of the Novartis production site in... Reuters Pictures logo Reuters Pictures 1 month ago

    Pascal Brenneisen (C) Country President at Novartis Group Switzerland speaks next to Philippe Leuba (L) member of the government Canton Vaud and Christoph Brutschin member of the government Canton Basel-Stadt during a news conference on the preservation of the Novartis production site in...

    View Photo »
  11. A general view shows the headquarters of Swiss drugmaker Novartis behind apartment buildings on the borders of the Rhine River in Basel October 29, 2011. Reuters Pictures logo Reuters Pictures 3 months ago

    A general view shows the headquarters of Swiss drugmaker Novartis behind apartment buildings on the borders of the Rhine River in Basel October 29, 2011.

    View Photo »
  12. A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board Daniel Vasella during a youth faction of the Socialist Party (Juso) "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the... Reuters Pictures logo Reuters Pictures 3 months ago

    A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board Daniel Vasella during a youth faction of the Socialist Party (Juso) "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the...

    View Photo »
  13. Workers from a plant of Swiss drugmaker Novartis in the western Swiss town of Nyon shout slogans as they arrive for a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies. Reuters Pictures logo Reuters Pictures 3 months ago

    Workers from a plant of Swiss drugmaker Novartis in the western Swiss town of Nyon shout slogans as they arrive for a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies.

    View Photo »
  14. The headquarters of Swiss drugmaker Novartis are seen behind as people carrying flags of Swiss Unia union cross a bridge over the Rhine River during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG... Reuters Pictures logo Reuters Pictures 3 months ago

    The headquarters of Swiss drugmaker Novartis are seen behind as people carrying flags of Swiss Unia union cross a bridge over the Rhine River during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG...

    View Photo »
  15. Novartis Diovan HCT Shellpak Wins HCPC Compliance Package of the Year. AP Photo logo AP Photo 9 months ago

    Novartis Diovan HCT Shellpak Wins HCPC Compliance Package of the Year.

    View Photo »
  16. An employee smokes a cigarette beside the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss... Reuters Pictures logo Reuters Pictures 3 months ago

    An employee smokes a cigarette beside the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss...

    View Photo »
  17. BASEL, SWITZERLAND - OCTOBER 25: Employees talk in front of Novartis headquarters on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD. Getty Images logo Getty Images 3 months ago

    BASEL, SWITZERLAND - OCTOBER 25: Employees talk in front of Novartis headquarters on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD.

    View Photo »
  18. BASEL, SWITZERLAND - OCTOBER 25: An employee looks down as he smokes in front of Novartis headquarters on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD. Getty Images logo Getty Images 3 months ago

    BASEL, SWITZERLAND - OCTOBER 25: An employee looks down as he smokes in front of Novartis headquarters on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD.

    View Photo »
  19. Traffic signs stand in front of an office building of Swiss drugmaker Novartis AG in Basel October 25, 2011. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss... Reuters Pictures logo Reuters Pictures 3 months ago

    Traffic signs stand in front of an office building of Swiss drugmaker Novartis AG in Basel October 25, 2011. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss...

    View Photo »
  20. People stand in front of the entrance of a Novartis production site in Nyon, Switzerland, Tuesday, Oct. 25, 2011. Swiss pharmaceutical giant Novartis AG posted a 7 percent increase in third-quarter net profit Tuesday as it announced 2,000 job cuts in an effort to save US dollar 200... AP Photo logo AP Photo 3 months ago

    People stand in front of the entrance of a Novartis production site in Nyon, Switzerland, Tuesday, Oct. 25, 2011. Swiss pharmaceutical giant Novartis AG posted a 7 percent increase in third-quarter net profit Tuesday as it announced 2,000 job cuts in an effort to save US dollar 200...

    View Photo »
  21. File photo of the headquarters of the drug making company Novartis in Basel January 17, 2008. Swiss drugmaker Novartis AG said October 25, 2011, it is slashing 2,000 jobs in Switzerland and the United States as it seeks to rake in annual savings of more than $200 million in the face of... Reuters Pictures logo Reuters Pictures 3 months ago

    File photo of the headquarters of the drug making company Novartis in Basel January 17, 2008. Swiss drugmaker Novartis AG said October 25, 2011, it is slashing 2,000 jobs in Switzerland and the United States as it seeks to rake in annual savings of more than $200 million in the face of...

    View Photo »
  22. File photo of people walking past the logo of Swiss drugmaker Novartis at the company's plant in Basel January 28, 2009. Swiss drugmaker Novartis AG said October 25, 2011, it is slashing 2,000 jobs in Switzerland and the United States as it seeks to rake in annual savings of more than... Reuters Pictures logo Reuters Pictures 3 months ago

    File photo of people walking past the logo of Swiss drugmaker Novartis at the company's plant in Basel January 28, 2009. Swiss drugmaker Novartis AG said October 25, 2011, it is slashing 2,000 jobs in Switzerland and the United States as it seeks to rake in annual savings of more than...

    View Photo »
  23. Joseph Jimenez, CEO, left, and Daniel Vasella, Chairman of Swiss pharmaceutical group Novartis, right, smile as they attend the extraordinary general assembly in Basel, Switzerland, Friday, April 8, 2011. Shareholders vote Friday on a US dollar 51 billion deal to buy Alcon eye care... AP Photo logo AP Photo 10 months ago

    Joseph Jimenez, CEO, left, and Daniel Vasella, Chairman of Swiss pharmaceutical group Novartis, right, smile as they attend the extraordinary general assembly in Basel, Switzerland, Friday, April 8, 2011. Shareholders vote Friday on a US dollar 51 billion deal to buy Alcon eye care...

    View Photo »
  24. COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe, center, shakes hands with U.S. Army veterinarian Col. G.C. Ritchie after announcing a donation to Guardian Angels for Soldier's Pets, in partnership with Sentinel Flavor Tabs (milbemycyn... AP Photo logo AP Photo 5 months ago

    COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe, center, shakes hands with U.S. Army veterinarian Col. G.C. Ritchie after announcing a donation to Guardian Angels for Soldier's Pets, in partnership with Sentinel Flavor Tabs (milbemycyn...

    View Photo »
  25. COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe and Axl, second left, meet with, from left, Army veterinarian Col. G.C. Ritchie, Air Force Maj. Dave Wilson and Navy Lt. Cdr. Sarah Higgins after announcing a donation to Guardian Angels for... AP Photo logo AP Photo 5 months ago

    COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe and Axl, second left, meet with, from left, Army veterinarian Col. G.C. Ritchie, Air Force Maj. Dave Wilson and Navy Lt. Cdr. Sarah Higgins after announcing a donation to Guardian Angels for...

    View Photo »
next
Getty Images logo Getty Images 3 months ago

BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen as trade union members give information to employee on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net...

View Photo »
View All »

Related Topics

  1. Malaria Malaria
  2. Pfizer Inc. Pfizer Inc.
  3. Diabetes Diabetes
  4. Paula Deen Paula Deen
  5. AstraZeneca PLC AstraZeneca PLC
  6. Merck & Co.

Timeline of Coverage

  1. Click to see all coverage from Jan 03, 2012
    5
    January 03, 2012
  2. Click to see all coverage from Jan 04, 2012
    4
    January 04, 2012
  3. Click to see all coverage from Jan 05, 2012
    3
    January 05, 2012
  4. Click to see all coverage from Jan 06, 2012
    8
    January 06, 2012
  5. Click to see all coverage from Jan 07, 2012
    1
    January 07, 2012
  6. Click to see all coverage from Jan 08, 2012
    122
    January 08, 2012
  7. Click to see all coverage from Jan 09, 2012
    340
    January 09, 2012
  8. Click to see all coverage from Jan 10, 2012
    62
    January 10, 2012
  9. Click to see all coverage from Jan 11, 2012
    9
    January 11, 2012
  10. Click to see all coverage from Jan 12, 2012
    3
    January 12, 2012
  11. Click to see all coverage from Jan 13, 2012
    202
    January 13, 2012
  12. Click to see all coverage from Jan 14, 2012
    15
    January 14, 2012
  13. Click to see all coverage from Jan 15, 2012
    2
    January 15, 2012
  14. Click to see all coverage from Jan 16, 2012
    18
    January 16, 2012
  15. Click to see all coverage from Jan 17, 2012
    14
    January 17, 2012
  16. Click to see all coverage from Jan 18, 2012
    22
    January 18, 2012
  17. Click to see all coverage from Jan 19, 2012
    11
    January 19, 2012
  18. Click to see all coverage from Jan 20, 2012
    129
    January 20, 2012
  19. Click to see all coverage from Jan 21, 2012
    4
    January 21, 2012
  20. Click to see all coverage from Jan 22, 2012
    4
    January 22, 2012
  21. Click to see all coverage from Jan 23, 2012
    5
    January 23, 2012
  22. Click to see all coverage from Jan 24, 2012
    4
    January 24, 2012
  23. Click to see all coverage from Jan 25, 2012
    136
    January 25, 2012
  24. Click to see all coverage from Jan 26, 2012
    13
    January 26, 2012
  25. Click to see all coverage from Jan 27, 2012
    21
    January 27, 2012
  26. Click to see all coverage from Jan 28, 2012
    0
    January 28, 2012
  27. Click to see all coverage from Jan 29, 2012
    12
    January 29, 2012
  28. Click to see all coverage from Jan 30, 2012
    18
    January 30, 2012
  29. Click to see all coverage from Jan 31, 2012
    19
    January 31, 2012
  30. Click to see all coverage from Feb 01, 2012
    14
    February 01, 2012
  31. Click to see all coverage from Feb 02, 2012
    14
    February 02, 2012
  32. Click to see all coverage from Feb 03, 2012
    2
    February 03, 2012
  33. Click to see all coverage from Feb 04, 2012
    0
    February 04, 2012
  34. Click to see all coverage from Feb 05, 2012
    2
    February 05, 2012
  35. Click to see all coverage from Feb 06, 2012
    7
    February 06, 2012
  36. Click to see all coverage from Feb 07, 2012
    9
    February 07, 2012
  37. Click to see all coverage from Feb 08, 2012
    5
    February 08, 2012
  38. Click to see all coverage from Feb 09, 2012
    7
    February 09, 2012
  39. Click to see all coverage from Feb 10, 2012
    7
    February 10, 2012
  40. Click to see all coverage from Feb 11, 2012
    1
    February 11, 2012
  41. Click to see all coverage from Feb 12, 2012
    2
    February 12, 2012
  42. Click to see all coverage from Feb 13, 2012
    4
    February 13, 2012
  43. Click to see all coverage from Feb 14, 2012
    5
    February 14, 2012
  44. Click to see all coverage from Feb 15, 2012
    11
    February 15, 2012
  45. Click to see all coverage from Feb 16, 2012
    5
    February 16, 2012
  46. Click to see all coverage from Feb 17, 2012
    9
    February 17, 2012
  47. Click to see all coverage from Feb 18, 2012
    1
    February 18, 2012
  48. Click to see all coverage from Feb 19, 2012
    0
    February 19, 2012

Related Videos

  1. Videosurf
    1. Novartis's Vasella Says Alcon Deal Won't Affect Ratings : Video
      Novartis's Vasella Says Alcon Deal Won't Affect...
    2. Novartis receives approval from FDA to market Prevacid® 24HR as first and only OTC proton pump inhibitor in original prescription formulation - Video
      Novartis receives approval from FDA to market P...
    3. Havens-Hasty Discusses Novartis Bid to Buy Rest of Alcon : Video
      Havens-Hasty Discusses Novartis Bid to Buy Rest...
    4. CNBC : Faber Report : Novartis-Alcon Deal
      CNBC : Faber Report : Novartis-Alcon Deal
      25 months ago
    5. CNBC : Faber Report : Novartis Eyes Alcon
      CNBC : Faber Report : Novartis Eyes Alcon
      25 months ago
    6. CNBC : Health of Novartis
      CNBC : Health of Novartis
      17 months ago

Related Quotes

  • Previous
  • Next
  • 1/13
  1. The proposed solutions that are intended to secure a sustainable profitability of the Nyon/Prangins site include the reduction of fixed costs and cantonal tax relief over a limited period
    – Novartis SOURCE: Reuters 1 month ago
  2. Sanofi vs Novartis: Paul Sorvino vs. Paula Deen
    SOURCE: Pharma Marketing Blog 1 month ago
  3. The rumors that Novartis has signed a multi-million dollar spokesperson deal with Paula Deen for a diabetes treatment are not true ... Novartis is not working with Ms. Deen.
    SOURCE: Pharma Marketing Blog 1 month ago
  4. The rumors that Novartis has signed a multimillion-dollar spokesperson deal with Paula Deen for a diabetes treatment are not true
    SOURCE: Detroit Free Press 1 month ago
  5. Novartis is not working with Ms. Deen.
    SOURCE: Detroit Free Press 1 month ago
  6. While Novartis submitted evidence that shows [Gilenya] can reduce relapses ... our independent committee has not been convinced that it is a cost-effective treatment option for the NHS, even with the proposed patient access scheme.
    SOURCE: FiercePharma 2 months ago
  7. While Novartis submitted evidence that shows fingolimod can reduce relapses, our independent committee has not been convinced that it is a cost effective treatment option
    SOURCE: Irish Times 2 months ago
  8. Novartis will continue to work with NICE and the U.K. department of health toward a solution that will allow patients access to this important therapy
    SOURCE: Bloomberg.com 2 months ago
  9. This decision has been made despite four independent appeals by the Royal College of Ophthalmologists, the Royal College of Nursing, Novartis and a joint appeal by the Royal National Institute of Blind People, the Macular Disease Society, Juvenile Diabetes Research Foundation and Diabetes UK
    SOURCE: Bloomberg.com 2 months ago
  10. We are working with industry sponsor [Novartis] to develop a confirmatory study in neuroendocrine tumors
    SOURCE: EurekAlert 2 months ago
  11. Phoenix views the new price conditions set by Novartis as inappropriate and thus unacceptable.
    SOURCE: FiercePharma 2 months ago
  12. As far as I know, there are a few (MNCs) in the country. At the moment, I can see Novartis is working with the Sarawak State Government in this area in Sarawak, looking into herbs and identifying certain herbal products. Once you turn these into medicine, you can export it
    SOURCE: Mmail 2 months ago
  13. The price conditions presented by Novartis were unreasonable in Phoenix’s view and therefore couldn’t be accepted
    SOURCE: Bloomberg.com 2 months ago